Doximity (NYSE
OCS) is one of the most promising mid-cap healthcare stocks under $50. On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSEOCS). He assigned a Buy rating to the stock with a $82 price target. This implies a highly attractive 88%…Continue reading...